A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Clinical trial NCT07102381 · RECRUITING
Trial details
- NCT number
- NCT07102381
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-24
- Primary completion
- 2028-01-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.